Heart Failure: Focus on Management and Prognosis

A special issue of Journal of Cardiovascular Development and Disease (ISSN 2308-3425). This special issue belongs to the section "Cardiovascular Clinical Research".

Deadline for manuscript submissions: 31 December 2025 | Viewed by 214

Special Issue Editor


E-Mail Website
Guest Editor
Cardiology Department, Ospedale di Rovereto, 38123 Rovereto, Italy
Interests: remote monitoring; cardiac pacing; device therapy; arrhythmias; heart failure
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Heart failure has a prevalence of 1–2% in the general population, but this rises to 20% in patients over 80 years old. Considering the aging of the population and the improvements in cardiology care, these numbers are destined to rise. Heart failure is responsible for 5–10% of all hospitalizations and is the most frequent cause of hospitalization in patients over 65 years old in Europe. In total, 75% of the costs of this pathology are related to hospitalization and each new heart failure event increases the risk of new hospitalization and patient mortality.

From these considerations, the need to strengthen the management of patients (as hospitals are not able to manage this number of patients), to reduce the costs of the pathology and to try to manage patients in a preclinical phase, before they reach hospitalization, arises. Telemedicine can be very useful in this regard to enable integrated patient management between the hospital and the general practitioner, monitor the patient and prevent hospitalizations, and educate the patient in recognizing and managing symptoms.

Dr. Massimiliano Maines
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • heart failure
  • remote monitoring
  • telemedicine
  • device
  • patient management

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

12 pages, 3394 KiB  
Article
Remote Heart Failure Patients Telemonitoring: Results of the TreC Heart Failure Study
by Massimiliano Maines, Annachiara Benini, Annalisa Vinci, Anna Manica, Elisa Erbogasto, Giancarlo Tomasi, Luisa Poian, Luigi Martinelli, Lorenzo Gios, Stefano Forti, Luigi Patil, William Mantovani and Maurizio Del Greco
J. Cardiovasc. Dev. Dis. 2025, 12(5), 182; https://doi.org/10.3390/jcdd12050182 - 13 May 2025
Viewed by 152
Abstract
(1) Aims: In our study, we evaluated the effectiveness of a telemonitoring program based on a nursing clinic, supported by a physician who remotely monitors patients via a dedicated application (TreC Cardiology), in reducing visits and hospitalizations for HF in patients affected by [...] Read more.
(1) Aims: In our study, we evaluated the effectiveness of a telemonitoring program based on a nursing clinic, supported by a physician who remotely monitors patients via a dedicated application (TreC Cardiology), in reducing visits and hospitalizations for HF in patients affected by HF living in Trentino in Italy. (2) Methods and Results: The TreC Heart Failure (TreC HF) study prospectively enrolled consecutive patients diagnosed with HF who attended our outpatient clinic and who were provided with the TreC Cardiology application. We analyzed primarily the number of visits and hospitalizations, comparing the year before and after the enrollment. From March 2021 to June 2023, we enrolled 211 patients, predominantly male (70.1%) and with a mean age of 71.5 ± 12.6 years. At baseline, 43.6% of patients were diagnosed with HFrEF, 28% with HFmrEF, and 28.4% with HFpEF. The mean left-ventricular ejection fraction (LV-EF) was 43.2 ± 11.9%. Outpatient visits in the year before the enrollment were on average 2.0 ± 1.2 vs. 1.6 ± 1.3 (p = 0.002) in the same following period. The percentage of patients who were hospitalized for heart failure went from 25.6% to 4.7% (p < 0.001). Analyzing HF categories separately, we found that, in the HFrEF population, after the enrollment, hospitalization for HF significantly decreased (32.6% vs. 7.6%, p < 0.001), while the number of outpatient visits did not vary (2.1 ± 1.4 vs. 2.1 ± 1.3, p = 0.795). In HFmrEF patients, both hospitalization for HF and outpatient visits significantly decreased (respectively, 30.5% vs. 1.7%, p < 0.001 and 2.0 ± 1.0 vs. 1.5 ± 1.3, p = 0.025). Finally, in the HFpEF population, only the number of outpatient visits significantly decreased after the enrollment (2.0 ± 1.1 vs. 1.0 ± 0.8, p < 0.001). (3) Conclusions: Our results confirm the enormous potential of telemonitoring, since in a real-world population affected by heart failure, it resulted in a significant reduction in hospitalization for HF and the number of outpatient visits. Full article
(This article belongs to the Special Issue Heart Failure: Focus on Management and Prognosis)
Show Figures

Figure 1

Back to TopTop